Characterization of an animal model of chronic infection and disease
慢性感染和疾病动物模型的表征
基本信息
- 批准号:7835663
- 负责人:
- 金额:$ 7.67万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-05-08 至 2011-04-30
- 项目状态:已结题
- 来源:
- 关键词:Animal ModelB-Cell LymphomasB-LymphocytesBenignBiological ModelsCellsChronicChronic DiseaseClonalityCritical PathwaysDefectDevelopmentDiseaseDisease OutcomeDisease modelEmployee StrikesEnvironmental Risk FactorFutureGene ExpressionGeneticGoalsHIVHumanHuman Herpesvirus 4ImmuneImmunologic Deficiency SyndromesIndividualInfectionInflammationInflammatoryInterferon Type IIKaposi SarcomaLeadLesionLungLung LymphomaLymphomaLymphomagenesisLymphoproliferative DisordersMalignant NeoplasmsModelingMolecularMusNatureNeoplasmsOutcomePilot ProjectsPneumoniaSatellite VirusesStagingTestingTimeUrsidae FamilyViralViral GenesVirusVirus Diseasesbasecell typecohortcytokinegammaherpesvirusinfected B cellinsightmouse modelneoplastic cellpublic health relevancetranslational studytumortumor progression
项目摘要
DESCRIPTION (provided by applicant): Gammaherpesviruses cause lifelong infection and are associated with various diseases, particularly in immune deficient hosts. The human gammaherpesviruses, Epstein Barr virus (EBV) and Kaposi's sarcoma associated virus, are associated with a number of malignancies, including lymphoproliferative disease and lymphomas. Murine gammaherpesvirus-68 is a genetically and biologically conserved with the human gammaherpesviruses, and naturally infects mice. We recently identified that gammaherpesvirus-68 infection of mice unresponsive to the cytokine interferon-gamma results in significant angiocentric inflammation in the lung with variable progression to frank lymphoma within five to nine months of infection. The inflammatory lesions in these individuals are rich in B cells and in virus-infected cells, and the resulting lymphomas are composed primarily of virus-infected B cells. These lesions and lymphomas bear striking similarity to human pulmonary lymphomas associated with chronic virus infection (including EBV). In this proposal for a pilot study, our goal is to extend our initial characterization of these immunodeficiency-associated lymphomas. First, we propose to finalize basic characterization of full cohorts of interferon-gamma unresponsive mice that are mock treated or infected with gammaherpesvirus for up to one year. We will determine tumor-free survival, tumor cell type and virus infection status of lymphoma cells. Second, we will characterize clonality, cell type composition, and virus gene expression of these immunodeficiency- associated lymphomas. Our long-term goal for these studies is the development of a small animal model for immunodeficiency-associated lymphomagenesis that will elucidate the molecular mechanisms that contribute to chronic infection-associated malignancies, to gain new insights into similar human neoplasms and facilitate translational studies. PUBLIC HEALTH RELEVANCE: Characterization of an animal model of chronic infection and disease. Chronic virus infection and immune defects can lead to variable disease outcomes. This pilot study will provide a valuable model system to further our understanding of human pulmonary lymphomas. This study of inflammation and lymphoma associated with chronic virus infection will set the stage for future studies to define the genetic and environmental risks for these tumors, the viral and host contributors to tumor progression, and the critical pathways that could be disrupted for successful therapies.
描述(由申请人提供):伽玛疱疹病毒引起终生感染并与多种疾病相关,特别是在免疫缺陷宿主中。人类伽马疱疹病毒、EB 病毒 (EBV) 和卡波西肉瘤相关病毒与许多恶性肿瘤有关,包括淋巴组织增生性疾病和淋巴瘤。鼠伽马疱疹病毒 68 是一种在遗传和生物学上与人类伽马疱疹病毒保守的病毒,自然感染小鼠。我们最近发现,对细胞因子干扰素-γ 无反应的小鼠感染伽马疱疹病毒 68 会导致肺部出现显着的血管中心性炎症,并在感染后 5 至 9 个月内不同程度地进展为弗兰克淋巴瘤。这些个体的炎症病变富含B细胞和病毒感染的细胞,所产生的淋巴瘤主要由病毒感染的B细胞组成。这些病变和淋巴瘤与慢性病毒感染(包括 EBV)相关的人类肺淋巴瘤具有惊人的相似性。在这项试点研究提案中,我们的目标是扩展我们对这些免疫缺陷相关淋巴瘤的初步表征。首先,我们建议最终确定接受伽马疱疹病毒模拟治疗或感染长达一年的干扰素伽马无反应小鼠的基本特征。我们将确定淋巴瘤细胞的无瘤生存、肿瘤细胞类型和病毒感染状态。其次,我们将描述这些免疫缺陷相关淋巴瘤的克隆性、细胞类型组成和病毒基因表达。我们这些研究的长期目标是开发一种用于免疫缺陷相关淋巴瘤发生的小动物模型,该模型将阐明导致慢性感染相关恶性肿瘤的分子机制,以获得对类似人类肿瘤的新见解并促进转化研究。公共卫生相关性:慢性感染和疾病动物模型的特征。慢性病毒感染和免疫缺陷可能导致不同的疾病结果。这项试点研究将为进一步了解人类肺淋巴瘤提供一个有价值的模型系统。这项关于与慢性病毒感染相关的炎症和淋巴瘤的研究将为未来的研究奠定基础,以确定这些肿瘤的遗传和环境风险、肿瘤进展的病毒和宿主因素,以及成功治疗可能被破坏的关键途径。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Linda F. Van Dyk其他文献
Linda F. Van Dyk的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Linda F. Van Dyk', 18)}}的其他基金
Non-coding RNAs in Gammaherpesvirus Infection and Disease
伽马疱疹病毒感染和疾病中的非编码 RNA
- 批准号:
9263885 - 财政年份:2016
- 资助金额:
$ 7.67万 - 项目类别:
Regulation of Herpesvirus Infection by Viral miRNAs
病毒 miRNA 对疱疹病毒感染的调控
- 批准号:
8535928 - 财政年份:2012
- 资助金额:
$ 7.67万 - 项目类别:
Cyclin requirements in gammaherpesvirus infection and disease
伽马疱疹病毒感染和疾病中的细胞周期素需求
- 批准号:
8685199 - 财政年份:2012
- 资助金额:
$ 7.67万 - 项目类别:
Cyclin requirements in gammaherpesvirus infection and disease
伽马疱疹病毒感染和疾病中的细胞周期素需求
- 批准号:
8456067 - 财政年份:2012
- 资助金额:
$ 7.67万 - 项目类别:
Cyclin requirements in gammaherpesvirus infection and disease
伽马疱疹病毒感染和疾病中的细胞周期素需求
- 批准号:
8329877 - 财政年份:2012
- 资助金额:
$ 7.67万 - 项目类别:
Cyclin requirements in gammaherpesvirus infection and disease
伽马疱疹病毒感染和疾病中的细胞周期素需求
- 批准号:
8852568 - 财政年份:2012
- 资助金额:
$ 7.67万 - 项目类别:
Characterization of an animal model of chronic infection and disease
慢性感染和疾病动物模型的表征
- 批准号:
7642162 - 财政年份:2009
- 资助金额:
$ 7.67万 - 项目类别:
相似国自然基金
揭开B细胞淋巴瘤“神秘面纱”——七鳃鳗胞苷脱氨酶介导可变淋巴细胞受体装配机制研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
GVAX肿瘤疫苗协同MyD88通过活化肿瘤浸润T淋巴细胞重塑弥漫大B细胞淋巴瘤免疫抑制微环境的作用机制研究
- 批准号:82000193
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
人工APCs刺激T细胞对CD19-CD20-CAR在B淋巴细胞瘤治疗效果的研究
- 批准号:81802848
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
调肝健脾解毒方通过Bcl-6/Blimp-1轴调控滤泡性T细胞功能促进慢性乙肝HBeAg转阴的机制研究
- 批准号:81804033
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
CD20膜转运障碍介导B淋巴细胞瘤对美罗华耐药的机制研究
- 批准号:81700190
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Selective targeting of a Rho GTPase mutant for peripheral T cell lymphoma treatment
选择性靶向 Rho GTPase 突变体治疗外周 T 细胞淋巴瘤
- 批准号:
10721439 - 财政年份:2023
- 资助金额:
$ 7.67万 - 项目类别:
"Project 3" Defining the in vivo function of ncRNAs during MHV68 latency and lymphomagenesis
“项目 3”定义 ncRNA 在 MHV68 潜伏期和淋巴瘤发生过程中的体内功能
- 批准号:
10865790 - 财政年份:2023
- 资助金额:
$ 7.67万 - 项目类别:
Gammaherpesvirus protein kinase: a master manipulator of the host during chronic infection.
伽玛疱疹病毒蛋白激酶:慢性感染期间宿主的主要操纵者。
- 批准号:
10518464 - 财政年份:2022
- 资助金额:
$ 7.67万 - 项目类别:
Investigating and modeling MYD88L265P and co-occurring mutations in mature B-cell malignancies
研究和建模 MYD88L265P 和成熟 B 细胞恶性肿瘤中同时发生的突变
- 批准号:
10501718 - 财政年份:2022
- 资助金额:
$ 7.67万 - 项目类别:
Gammaherpesvirus protein kinase: a master manipulator of the host during chronic infection.
伽玛疱疹病毒蛋白激酶:慢性感染期间宿主的主要操纵者。
- 批准号:
10651854 - 财政年份:2022
- 资助金额:
$ 7.67万 - 项目类别: